Effects of Doxazosin Gastrointestinal Therapeutic System on Ambulatory Blood Pressure and Cardiovascular Risk Factors in Uncontrolled Hypertensive Patients
Clinical trial NCT00646841 · COMPLETED
Trial details
- NCT number
- NCT00646841
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-02-01
- Primary completion
- 2004-02-01
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.